| Trial ID: | L2791 |
| Source ID: | NCT00572689
|
| Associated Drug: |
Exenatide
|
| Title: |
Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Gestational Diabetes
|
| Interventions: |
DRUG: Exenatide|GENETIC: Buccal/blood Sample Collection
|
| Outcome Measures: |
Primary: glycemic control through insulin, glucose, c-peptide and glucagon assays, duing testing days | Secondary: TCF7L2 polymorphism, During subject testing days|Exenatide Pharmacodynamics and Pharmacokinetics, During testing days
|
| Sponsor/Collaborators: |
Sponsor: Georgetown University | Collaborators: Medstar Health Research Institute
|
| Gender: |
FEMALE
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
|
| Start Date: |
2013-08
|
| Completion Date: |
2015-08
|
| Results First Posted: |
|
| Last Update Posted: |
2015-08-21
|
| Locations: |
Georgetown University Medical Center, Washington, District of Columbia, 20007, United States|Washington Hospital Center, Washington, District of Columbia, 20010, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00572689
|
